Neumentum: Funding, Investors & Team (Oct 2026)
Neumentum neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products. At Neumentum, we are dedicated to developing safe, effective treatment options that address unmet needs in the management of pain, without the potential risks of misuse, addiction, or life-threatening side effects that may be found with opioid products. Neumentum has global rights to five novel non-opioid pain products, the most advanced of which are two phase 3-ready injectable products under development for acute postsurgical pain.
Neumentum has raised $13.3M across 1 funding round on record, the most recent an undisclosed round of $13.3M announced in Oct 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neumentum Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Neumentum Funding Rounds
Neumentum Founders and Leadership Team
No contact details are on record for this team yet.
Neumentum Funding Compared to Other Biotechnology Startups
Neumentum's latest round of $13.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neumentum in Biotechnology and Morristown
Companies Similar to Neumentum
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Neumentum Funding FAQs
What does Neumentum do?
Neumentum neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products. At Neumentum, we are dedicated to developing safe, effective treatment options that address unmet needs in the management of pain, without the potential risks of misuse, addiction, or life-threatening side effects that may be found with opioid products. Neumentum has global rights to five novel non-opioid pain products, the most advanced of which are two phase 3-ready injectable products under development for acute postsurgical pain.
How much funding has Neumentum raised?
Neumentum has raised $13.3M across 1 round on record. The most recent is an undisclosed round of $13.3M announced in Oct 2021.
When did Neumentum last raise funding?
Neumentum's most recent funding round on record is an undisclosed round of $13.3M, announced in Oct 2021.
Who is the CEO of Neumentum?
Scott Shively is listed as CEO at Neumentum.
Where is Neumentum headquartered?
Neumentum is based in Morristown, New Jersey, United States.
How many employees does Neumentum have?
Neumentum is in the 1-10 employee band.
How does Neumentum's funding compare to other Biotechnology startups?
Neumentum's latest round of $13.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Neumentum Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neumentum is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.